Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1ALXN1850----1件: 172 💬
2Asfotas alfa----1件: 172 💬
3Asfotase alfa1件: Asfotase alfa1件: Asfotase alfa 💬 1件: E3.1.3.1 💬 2件: Folate biosynthesis, Thiamine metabolism 💬1件: 172 💬
4Bioelectrical impedance analysis----1件: 172 💬
5Bortezomib2件: Bortezomib,
Bortezomib D-mannitol		1件: Bortezomib 💬 1件: PSMB5 💬 8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬16件: 11, 13, 26, 28, 46, 49, 51, 61, 63, 66, 172, 222, 228, 256, 288, 331 💬
6BPS804----2件: 172, 274 💬
7Cyclophosphamide1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--44件: 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 93, 96, 162, 164, 172, 205, 221, 222, 224, 265, 274, 283, 284, 285, 288, 326, 331 💬
8ENB-0040----1件: 172 💬
9Extended laboratory diagnostics----1件: 172 💬
10Folic acid1件: Folic acid2件: Folic acid ,
Folate sodium 💬 		--6件: 46, 84, 96, 97, 172, 296 💬
11Fully human IGG2 lambda monoclonal antibody----1件: 172 💬
12Genetic testing OF THE alkaline phosphatase gene----1件: 172 💬
13Human recombinant tissue NON-specific alkaline phosphatase fusion protein----1件: 172 💬
14Ilofotase alfa, 0.8 MG/KG1件: Recombinant human alkaline phosphatase1件: Ilofotase alfa 💬 1件: E3.1.3.1 💬 2件: Folate biosynthesis, Thiamine metabolism 💬1件: 172 💬
15Ilofotase alfa, 3.2 MG/KG1件: Recombinant human alkaline phosphatase1件: Ilofotase alfa 💬 1件: E3.1.3.1 💬 2件: Folate biosynthesis, Thiamine metabolism 💬1件: 172 💬
16Ivig----8件: 11, 13, 14, 35, 51, 63, 65, 172 💬
17Methotrexate1件: Methotrexate2件: Methotrexate ,
Methotrexate sodium 💬 		2件: DHFR,
DHFR 💬 		3件: Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬37件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 54, 55, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 284, 285, 286, 326, 331 💬
18Microindentation----1件: 172 💬
19Physical examination----2件: 49, 172 💬
20Recording OF vital signs----1件: 172 💬
21Retrospective case only----1件: 172 💬
22Rituximab1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬52件: 11, 13, 14, 19, 26, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 172, 220, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
23Second alkaline phosphatase measurement----1件: 172 💬
24SF-36----1件: 172 💬
25Short physical performance battery (sppb) score----1件: 172 💬
26Strensiq1件: Asfotase alfa1件: Asfotase alfa 💬 1件: E3.1.3.1 💬 2件: Folate biosynthesis, Thiamine metabolism 💬1件: 172 💬
27Symptom and clinical findings checklist FOR hypophosphatasia----1件: 172 💬
28Teriparatide1件: Teriparatide3件: Teriparatide acetate ,
Teriparatide ,
Teriparatide acetate 💬 		1件: PTH1R 💬 4件: Endocrine and other factor-regulated calcium reabsorption, Hormone signaling, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬7件: 46, 68, 70, 71, 172, 235, 274 💬
29Whole genome sequencing----5件: 2, 6, 79, 127, 172 💬